(Combined Hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women) - B. de Lignieres, F. de Vathaire, S. Fournier, R. Urbinelli, F. Allaert, M.G. Le, F. Kutten Climateric 2002, 5, 332-340

By Cohen J.  

Gynecology Obstetrique & Fertilite, Vol. 31, Iss. 6, 2003-06 ,pp. : 576-576

Elsevier

Access to resources Recommend Favorite

Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study

By Dew J. E.   Wren B. G.   Eden J. A.  

Climacteric, Vol. 5, Iss. 2, 2002-06 ,pp. : 151-155

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women

By Cerne J. Z.   Ferk P.   Leskosek B.   Gersak K.  

Climacteric, Vol. 14, Iss. 4, 2011-08 ,pp. : 458-463

Informa Healthcare

Access to resources Recommend Favorite

Does hormone replacement therapy increase the risk of breast cancer?

By Lecuru F.   Laforest H.   Darles C.   Taurelle R.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 62, Iss. 2, 1995-10 ,pp. : 159-166

Elsevier

Access to resources Recommend Favorite

Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women

By Mizunuma H.   Honjo H.   Aso T.   Urabe M.   Ohta H.   Kobayashi S.   Sagara Y.   Sanada M.   Tanaka K.   Dobashi K.   Hayashi K.   Ohama K.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 293-298

Informa Healthcare

Access to resources Recommend Favorite